Oct 18 (Reuters) - Abbott Laboratories
ABT.N
and St. Jude Medical Inc
STJ.N
said they would sell some of their medical devices to Japan-based Terumo Corp
4543.T
for about $1.12 billion.
The all-cash transaction will include St. Jude Medical's Angio-Seal and Femoseal vascular closure products and Abbott's Vado Steerable Sheath.
Abbott said the deal is an important step toward completion of its acquisition of St. Jude Medical, which is expected to close by the year-end.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj Kalluvila) ((ankur.banerjee@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132; Reuters Messaging: ankur.banerjee.thomsonreuters.com@reuters.net))
The all-cash transaction will include St. Jude Medical's Angio-Seal and Femoseal vascular closure products and Abbott's Vado Steerable Sheath.
Abbott said the deal is an important step toward completion of its acquisition of St. Jude Medical, which is expected to close by the year-end.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj Kalluvila) ((ankur.banerjee@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132; Reuters Messaging: ankur.banerjee.thomsonreuters.com@reuters.net))
